These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8578950)

  • 1. Urinary excretion of melanocyte metabolites during treatment with chloroquine phosphate.
    Sjölin-Forsberg G; Hansson C; Kågedal B; Gannedahl EL; Berne B
    Acta Derm Venereol; 1995 Jul; 75(4):287-9. PubMed ID: 8578950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus.
    Lesiak A; Narbutt J; Sysa-Jedrzejowska A; Lukamowicz J; McCauliffe DP; Wózniacka A
    Lupus; 2010 May; 19(6):683-8. PubMed ID: 20064914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimalarial therapy in SLE.
    Lanham JG; Hughes GR
    Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
    [No Abstract]   [Full Text] [Related]  

  • 4. In situ localization of chloroquine and immunohistological studies in UVB-irradiated skin of photosensitive patients.
    Sjölin-Forsberg G; Berne B; Eggelte TA; Karlsson-Parra A
    Acta Derm Venereol; 1995 May; 75(3):228-31. PubMed ID: 7653184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters.
    Wozniacka A; Cygankiewicz I; Chudzik M; Sysa-Jedrzejowska A; Wranicz JK
    Lupus; 2006; 15(8):521-5. PubMed ID: 16942005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloroquine: its therapeutic use in photosensitive eruptions.
    Sams WM
    Int J Dermatol; 1976 Mar; 15(2):99-111. PubMed ID: 767269
    [No Abstract]   [Full Text] [Related]  

  • 7. Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.
    Meinão IM; Sato EI; Andrade LE; Ferraz MB; Atra E
    Lupus; 1996 Jun; 5(3):237-41. PubMed ID: 8803897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimalarial drugs, systemic lupus erythematosus and pregnancy.
    Parke AL
    J Rheumatol; 1988 Apr; 15(4):607-10. PubMed ID: 3397970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort.
    Spinelli FR; Moscarelli E; Ceccarelli F; Miranda F; Perricone C; Truglia S; Garufi C; Massaro L; Morello F; Alessandri C; Valesini G; Conti F
    Lupus; 2018 Sep; 27(10):1616-1623. PubMed ID: 29954281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarials and ophthalmologic safety.
    Olansky AJ
    J Am Acad Dermatol; 1982 Jan; 6(1):19-23. PubMed ID: 7045172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of discoid lupus erythematosus, polymorphous photodermatosis and rosacea with Triquin--a combination of 3 anti-malarials].
    FREDRIKSSON T; LODIN A; ROSENGREN S
    Sven Lakartidn; 1962 Oct; 59():2858-62. PubMed ID: 13959402
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of delagil in psoriasis, photodermatosis and discoid erythematodes.
    Lakos T
    Ther Hung; 1968; 16(1):33-7. PubMed ID: 5651019
    [No Abstract]   [Full Text] [Related]  

  • 13. Retinal nerve fibre layer thickness measurements in patients using chloroquine.
    Bonanomi MT; Dantas NC; Medeiros FA
    Clin Exp Ophthalmol; 2006 Mar; 34(2):130-6. PubMed ID: 16626426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients opinion and adherence to antimalarials in lupus erythematosus and rheumatoid arthritis treatment.
    Cabral RTS; Klumb EM; Carneiro S
    J Dermatolog Treat; 2020 May; 31(3):264-269. PubMed ID: 30935255
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of lupus erythematosus with crystalline synthetic antimalarials: nivaquine & flavoquine].
    GRUPPER C
    Vie Med; 1957 Jun; 38(Spec No):119-22. PubMed ID: 13456299
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of patients with discoid lupus erythematosus by injections of 10 per cent Quingamine].
    Zheltakov MM; Sharapova GIa; Khamaganova AV; Berezhnoĭ IuZ
    Vestn Dermatol Venerol; 1969 Dec; 45(12):8-11. PubMed ID: 5375472
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunofluorescent "band" test for lupus erythematosus. II. Employing skin lesions.
    Burnham TK; Neblett TR; Fine G
    Arch Dermatol; 1970 Jul; 102(1):42-50. PubMed ID: 4925010
    [No Abstract]   [Full Text] [Related]  

  • 18. [Presocyl in the treatment of lupus erythematosus].
    Glavinskaia TA; Zernov VP; Ostroumova TN
    Vestn Dermatol Venerol; 1976 Jul; (7):51-3. PubMed ID: 997883
    [No Abstract]   [Full Text] [Related]  

  • 19. The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus.
    Feldmann R; Salomon D; Saurat JH
    Dermatology; 1994; 189(4):425-7. PubMed ID: 7873836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular side effects of chloroquine in patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma.
    Leecharoen S; Wangkaew S; Louthrenoo W
    J Med Assoc Thai; 2007 Jan; 90(1):52-8. PubMed ID: 17621733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.